{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:37:52Z","timestamp":1794843472466,"version":"4.9.1"},"reference-count":242,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["019562"],"award-info":[{"award-number":["019562"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["023925"],"award-info":[{"award-number":["023925"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1NS128800"],"award-info":[{"award-number":["RF1NS128800"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","award":["RCE-1945"],"award-info":[{"award-number":["RCE-1945"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Parkinson\u2019s disease (PD) is a multi-system disorder characterized histopathologically by degeneration of dopaminergic neurons in the <jats:italic>substantia nigra pars compacta<\/jats:italic>. While the etiology of PD remains multifactorial and complex, growing evidence suggests that cellular metabolic dysfunction is a critical driver of neuronal death. Defects in cellular metabolism related to energy production, oxidative stress, metabolic organelle health, and protein homeostasis have been reported in both neurons and immune cells in PD. We propose that these factors act synergistically in immune cells to drive aberrant inflammation in both the CNS and the periphery in PD, contributing to a hostile inflammatory environment which renders certain subsets of neurons vulnerable to degeneration. This review highlights the overlap between established neuronal metabolic deficits in PD with emerging findings in central and peripheral immune cells. By discussing the rapidly expanding literature on immunometabolic dysfunction in PD, we aim to draw attention to potential biomarkers and facilitate future development of immunomodulatory strategies to prevent or delay the progression of PD.<\/jats:p>","DOI":"10.1186\/s13024-025-00827-y","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T22:26:10Z","timestamp":1742855170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Immune cell metabolic dysfunction in Parkinson\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Julian R.","family":"Mark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1719-4708","authenticated-orcid":false,"given":"Mal\u00fa G\u00e1mez","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"827_CR1","doi-asserted-by":"publisher","first-page":"776847","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S, et al. Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health. 2021;9:776847.","journal-title":"Front Public Health"},{"issue":"19","key":"827_CR2","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ. Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. Febs J. 2018;285(19):3657\u201368.","journal-title":"Febs J"},{"key":"827_CR3","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fnagi.2018.00301","volume":"10","author":"JW B\u0142aszczyk","year":"2018","unstructured":"B\u0142aszczyk JW. The emerging role of energy metabolism and neuroprotective strategies in Parkinson\u2019s disease. Front Aging Neurosci. 2018;10:301.","journal-title":"Front Aging Neurosci"},{"key":"827_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","volume":"133","author":"A Anandhan","year":"2017","unstructured":"Anandhan A, Jacome MS, Lei S, et al. Metabolic dysfunction in Parkinson\u2019s disease: bioenergetics, redox homeostasis and central carbon metabolism. Brain Res Bull. 2017;133:12\u201330.","journal-title":"Brain Res Bull"},{"issue":"1","key":"827_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/jnc.13572","volume":"139","author":"J Duda","year":"2016","unstructured":"Duda J, P\u00f6tschke C, Liss B. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of substantia Nigra dopaminergic neurons in health and Parkinson\u2019s disease. J Neurochem. 2016;139(1):156\u201378.","journal-title":"J Neurochem"},{"key":"827_CR6","doi-asserted-by":"crossref","unstructured":"Haas RH. Mitochondrial dysfunction in aging and diseases of aging. Biology (Basel) 2019;8(2).","DOI":"10.3390\/biology8020048"},{"issue":"2","key":"827_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH. Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol. 2015;24(2):103\u201316.","journal-title":"Exp Neurobiol"},{"issue":"11","key":"827_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"827_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3233\/JPD-202508","volume":"11","author":"LP Hughes","year":"2021","unstructured":"Hughes LP, Pereira MMM, Hammond DA, et al. Glucocerebrosidase activity is reduced in cryopreserved Parkinson\u2019s disease patient monocytes and inversely correlates with motor severity. J Parkinsons Dis. 2021;11(3):1157\u201365.","journal-title":"J Parkinsons Dis"},{"key":"827_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neulet.2019.04.003","volume":"704","author":"N Papagiannakis","year":"2019","unstructured":"Papagiannakis N, Xilouri M, Koros C, et al. Autophagy dysfunction in peripheral blood mononuclear cells of Parkinson\u2019s disease patients. Neurosci Lett. 2019;704:112\u20135.","journal-title":"Neurosci Lett"},{"key":"827_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"827_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00429-010-0246-0","volume":"214","author":"P Borghammer","year":"2010","unstructured":"Borghammer P, Chakravarty M, Jonsdottir KY, et al. Cortical hypometabolism and hypoperfusion in Parkinson\u2019s disease is extensive: probably even at early disease stages. Brain Struct Funct. 2010;214(4):303\u201317.","journal-title":"Brain Struct Funct"},{"key":"827_CR13","doi-asserted-by":"crossref","unstructured":"Chandel NS, Glycolysis. Cold Spring Harb Perspect Biol. 2021;13(5).","DOI":"10.1101\/cshperspect.a040535"},{"issue":"2","key":"827_CR14","doi-asserted-by":"publisher","first-page":"102838","DOI":"10.1016\/j.jbc.2022.102838","volume":"299","author":"PK Arnold","year":"2023","unstructured":"Arnold PK, Finley LWS. Regulation and function of the mammalian Tricarboxylic acid cycle. J Biol Chem. 2023;299(2):102838.","journal-title":"J Biol Chem"},{"key":"827_CR15","volume-title":"The cell: A molecular approach","author":"G Cooper","year":"2000","unstructured":"Cooper G. The cell: A molecular approach. 2nd ed. Sunderland (MA): Sinauer Associates; 2000.","edition":"2"},{"issue":"11","key":"827_CR16","doi-asserted-by":"publisher","first-page":"107906","DOI":"10.1016\/j.jbc.2024.107906","volume":"300","author":"SJ Kierans","year":"2024","unstructured":"Kierans SJ, Taylor CT. Glycolysis: A multifaceted metabolic pathway and signaling hub. J Biol Chem. 2024;300(11):107906.","journal-title":"J Biol Chem"},{"key":"827_CR17","doi-asserted-by":"publisher","first-page":"101674","DOI":"10.1016\/j.redox.2020.101674","volume":"37","author":"D Nolfi-Donegan","year":"2020","unstructured":"Nolfi-Donegan D, Braganza A, Shiva S. Mitochondrial electron transport chain: oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37:101674.","journal-title":"Redox Biol"},{"issue":"1","key":"827_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12974-024-03296-0","volume":"21","author":"M Sadeghdoust","year":"2024","unstructured":"Sadeghdoust M, Das A, Kaushik DK. Fueling neurodegeneration: metabolic insights into microglia functions. J Neuroinflammation. 2024;21(1):300.","journal-title":"J Neuroinflammation"},{"key":"827_CR19","doi-asserted-by":"crossref","unstructured":"Han R, Liang J, Zhou B. Glucose metabolic dysfunction in neurodegenerative Diseases-New mechanistic insights and the potential of hypoxia as a prospective therapy targeting metabolic reprogramming. Int J Mol Sci 2021;22(11).","DOI":"10.3390\/ijms22115887"},{"issue":"1","key":"827_CR20","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"827_CR21","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.stemcr.2021.04.022","volume":"16","author":"J Okarmus","year":"2021","unstructured":"Okarmus J, Havelund JF, Ryding M, et al. Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: altered mitochondrial and energy metabolism. Stem Cell Rep. 2021;16(6):1510\u201326.","journal-title":"Stem Cell Rep"},{"issue":"10","key":"827_CR22","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1172\/JCI129987","volume":"129","author":"R Cai","year":"2019","unstructured":"Cai R, Zhang Y, Simmering JE, et al. Enhancing Glycolysis attenuates Parkinson\u2019s disease progression in models and clinical databases. J Clin Invest. 2019;129(10):4539\u201349.","journal-title":"J Clin Invest"},{"issue":"1","key":"827_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12974-022-02484-0","volume":"19","author":"J Lu","year":"2022","unstructured":"Lu J, Wang C, Cheng X, et al. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of \u03b1-synuclein in a mouse model of Parkinson\u2019s disease. J Neuroinflammation. 2022;19(1):113.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"827_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-021-02187-y","volume":"18","author":"J Cheng","year":"2021","unstructured":"Cheng J, Zhang R, Xu Z, et al. Early glycolytic reprogramming controls microglial inflammatory activation. J Neuroinflammation. 2021;18(1):129.","journal-title":"J Neuroinflammation"},{"key":"827_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2016.10.018","volume":"60","author":"R Gu","year":"2017","unstructured":"Gu R, Zhang F, Chen G, et al. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial metabolic reprogramming. Brain Behav Immun. 2017;60:206\u201319.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"827_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/glia.1107","volume":"36","author":"Y Dong","year":"2001","unstructured":"Dong Y, Benveniste EN. Immune function of astrocytes. Glia. 2001;36(2):180\u201390.","journal-title":"Glia"},{"issue":"1","key":"827_CR27","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1038\/s41598-020-63766-2","volume":"10","author":"KR Rodgers","year":"2020","unstructured":"Rodgers KR, Lin Y, Langan TJ, Iwakura Y, Chou RC. Innate immune functions of astrocytes are dependent upon tumor necrosis Factor-Alpha. Sci Rep. 2020;10(1):7047.","journal-title":"Sci Rep"},{"issue":"1","key":"827_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-021-00175-w","volume":"7","author":"P Ramos-Gonzalez","year":"2021","unstructured":"Ramos-Gonzalez P, Mato S, Chara JC, Verkhratsky A, Matute C, Cavaliere F. Astrocytic atrophy as a pathological feature of Parkinson\u2019s disease with LRRK2 mutation. NPJ Parkinsons Dis. 2021;7(1):31.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"827_CR29","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","volume":"10","author":"TM Sonninen","year":"2020","unstructured":"Sonninen TM, H\u00e4m\u00e4l\u00e4inen RH, Koskuvi M, et al. Metabolic alterations in Parkinson\u2019s disease astrocytes. Sci Rep. 2020;10(1):14474.","journal-title":"Sci Rep"},{"issue":"10","key":"827_CR30","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/mds.104","volume":"33","author":"AM Smith","year":"2018","unstructured":"Smith AM, Depp C, Ryan BJ, et al. Mitochondrial dysfunction and increased Glycolysis in prodromal and early Parkinson\u2019s blood cells. Mov Disord. 2018;33(10):1580\u201390.","journal-title":"Mov Disord"},{"key":"827_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","volume":"43","author":"A Galbiati","year":"2019","unstructured":"Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L. The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. 2019;43:37\u201346.","journal-title":"Sleep Med Rev"},{"key":"827_CR32","doi-asserted-by":"crossref","unstructured":"St Louis EK, Boeve BF. REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions. Mayo Clin Proc. 2017;92(11):1723\u20131736.","DOI":"10.1016\/j.mayocp.2017.09.007"},{"key":"827_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.parkreldis.2020.07.017","volume":"78","author":"H Zhang","year":"2020","unstructured":"Zhang H, Wang T, Li Y, et al. Plasma immune markers in an idiopathic REM sleep behavior disorder cohort. Parkinsonism Relat Disord. 2020;78:145\u201350.","journal-title":"Parkinsonism Relat Disord"},{"key":"827_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jocn.2018.10.079","volume":"58","author":"R Kim","year":"2018","unstructured":"Kim R, Kim HJ, Kim A, et al. Peripheral blood inflammatory markers in early Parkinson\u2019s disease. J Clin Neurosci. 2018;58:30\u20133.","journal-title":"J Clin Neurosci"},{"issue":"2","key":"827_CR35","doi-asserted-by":"publisher","first-page":"e00940","DOI":"10.1002\/prp2.940","volume":"10","author":"I Uehara","year":"2022","unstructured":"Uehara I, Kajita M, Tanimura A, et al. 2-Deoxy-d-glucose induces deglycosylation of Proinflammatory cytokine receptors and strongly reduces immunological responses in mouse models of inflammation. Pharmacol Res Perspect. 2022;10(2):e00940.","journal-title":"Pharmacol Res Perspect"},{"issue":"4","key":"827_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbabio.2013.10.004","volume":"1837","author":"Y Chaban","year":"2014","unstructured":"Chaban Y, Boekema EJ, Dudkina NV. Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation. Biochim Biophys Acta. 2014;1837(4):418\u201326.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"827_CR37","first-page":"3","volume":"44","author":"RZ Zhao","year":"2019","unstructured":"Zhao RZ, Jiang S, Zhang L, Yu ZB. Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med. 2019;44(1):3\u201315.","journal-title":"Int J Mol Med"},{"issue":"0 1","key":"827_CR38","first-page":"S32","volume":"25","author":"TM Dawson","year":"2010","unstructured":"Dawson TM, Dawson VL. The role of parkin in Familial and sporadic Parkinson\u2019s disease. Mov Disord. 2010;25(0 1):S32\u201339.","journal-title":"Mov Disord"},{"issue":"7","key":"827_CR39","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1073\/pnas.0737556100","volume":"100","author":"JC Greene","year":"2003","unstructured":"Greene JC, Whitworth AJ, Kuo I, Andrews LA, Feany MB, Pallanck LJ. Mitochondrial pathology and apoptotic muscle degeneration in drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003;100(7):4078\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"827_CR40","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","volume":"279","author":"JJ Palacino","year":"2004","unstructured":"Palacino JJ, Sagi D, Goldberg MS, et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem. 2004;279(18):18614\u201322.","journal-title":"J Biol Chem"},{"issue":"5","key":"827_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.stemcr.2015.02.019","volume":"4","author":"A Shaltouki","year":"2015","unstructured":"Shaltouki A, Sivapatham R, Pei Y, et al. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Rep. 2015;4(5):847\u201359.","journal-title":"Stem Cell Rep"},{"key":"827_CR42","doi-asserted-by":"crossref","unstructured":"Jia F, Fellner A, Kumar KR. Monogenic Parkinson\u2019s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing. Genes (Basel) 2022;13(3).","DOI":"10.3390\/genes13030471"},{"issue":"2","key":"827_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"AM Pickrell","year":"2015","unstructured":"Pickrell AM, Youle RJ. The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson\u2019s disease. Neuron. 2015;85(2):257\u201373.","journal-title":"Neuron"},{"issue":"1","key":"827_CR44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41531-021-00182-x","volume":"7","author":"C Chen","year":"2021","unstructured":"Chen C, McDonald D, Blain A, et al. Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2021;7(1):39.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"827_CR45","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41598-020-58505-6","volume":"10","author":"PMA Antony","year":"2020","unstructured":"Antony PMA, Kondratyeva O, Mommaerts K, et al. Fibroblast mitochondria in idiopathic Parkinson\u2019s disease display morphological changes and enhanced resistance to depolarization. Sci Rep. 2020;10(1):1569.","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"827_CR46","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF. Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem. 2016;139(Suppl 1):216\u201331.","journal-title":"J Neurochem"},{"issue":"1","key":"827_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF. Mitochondrial dysfunction in Parkinson\u2019s disease - a key disease hallmark with therapeutic potential. Mol Neurodegener. 2023;18(1):83.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"827_CR48","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A. Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(1):a008888.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"827_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s10038-022-01058-5","volume":"68","author":"M Funayama","year":"2023","unstructured":"Funayama M, Nishioka K, Li Y, Hattori N. Molecular genetics of Parkinson\u2019s disease: contributions and global trends. J Hum Genet. 2023;68(3):125\u201330.","journal-title":"J Hum Genet"},{"issue":"3","key":"827_CR50","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem. 1990;54(3):823\u20137.","journal-title":"J Neurochem"},{"issue":"2","key":"827_CR51","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/mds.28849","volume":"37","author":"C Chen","year":"2022","unstructured":"Chen C, Mossman E, Malko P, et al. Astrocytic changes in mitochondrial oxidative phosphorylation protein levels in Parkinson\u2019s disease. Mov Disord. 2022;37(2):302\u201314.","journal-title":"Mov Disord"},{"key":"827_CR52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41531-017-0032-2","volume":"3","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Malovic E, Harishchandra DS, et al. Mitochondrial impairment in microglia amplifies NLRP3 inflammasome Proinflammatory signaling in cell culture and animal models of Parkinson\u2019s disease. NPJ Parkinsons Dis. 2017;3:30.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"827_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/10599240801986215","volume":"13","author":"AS Dhillon","year":"2008","unstructured":"Dhillon AS, Tarbutton GL, Levin JL, et al. Pesticide\/environmental exposures and Parkinson\u2019s disease in East Texas. J Agromedicine. 2008;13(1):37\u201348.","journal-title":"J Agromedicine"},{"issue":"1","key":"827_CR54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/ije\/dyx225","volume":"47","author":"C Pouchieu","year":"2018","unstructured":"Pouchieu C, Piel C, Carles C, et al. Pesticide use in agriculture and Parkinson\u2019s disease in the AGRICAN cohort study. Int J Epidemiol. 2018;47(1):299\u2013310.","journal-title":"Int J Epidemiol"},{"issue":"45","key":"827_CR55","doi-asserted-by":"publisher","first-page":"27425","DOI":"10.1074\/jbc.M115.667063","volume":"290","author":"JH Won","year":"2015","unstructured":"Won JH, Park S, Hong S, Son S, Yu JW. Rotenone-induced impairment of mitochondrial electron transport chain confers a selective priming signal for NLRP3 inflammasome activation. J Biol Chem. 2015;290(45):27425\u201337.","journal-title":"J Biol Chem"},{"issue":"1","key":"827_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02257619","volume":"4","author":"H Yoshino","year":"1992","unstructured":"Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect.\u00a01992;4(1):27\u201334.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"5","key":"827_CR57","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/mds.10695","volume":"19","author":"M M\u00fcft\u00fcoglu","year":"2004","unstructured":"M\u00fcft\u00fcoglu M, Elibol B, Dalmizrak O, et al. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord. 2004;19(5):544\u20138.","journal-title":"Mov Disord"},{"issue":"3","key":"827_CR58","first-page":"678","volume":"19","author":"M Salemi","year":"2023","unstructured":"Salemi M, Cosentino F, Lanza G, et al. mRNA expression profiling of mitochondrial subunits in subjects with Parkinson\u2019s disease. Arch Med Sci. 2023;19(3):678\u201386.","journal-title":"Arch Med Sci"},{"issue":"12","key":"827_CR59","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat Neurosci. 2000;3(12):1301\u20136.","journal-title":"Nat Neurosci"},{"issue":"4587","key":"827_CR60","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219(4587):979\u201380.","journal-title":"Science"},{"issue":"141","key":"827_CR61","doi-asserted-by":"publisher","first-page":"141ra190","DOI":"10.1126\/scitranslmed.3003985","volume":"4","author":"O Cooper","year":"2012","unstructured":"Cooper O, Seo H, Andrabi S, et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with Familial Parkinson\u2019s disease. Sci Transl Med. 2012;4(141):141ra190.","journal-title":"Sci Transl Med"},{"issue":"32","key":"827_CR62","doi-asserted-by":"publisher","first-page":"11364","DOI":"10.1073\/pnas.0802076105","volume":"105","author":"CA Gautier","year":"2008","unstructured":"Gautier CA, Kitada T, Shen J. Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A. 2008;105(32):11364\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"827_CR63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/neuro.24.003.2009","volume":"1","author":"G Patki","year":"2009","unstructured":"Patki G, Che Y, Lau YS. Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson\u2019s disease. Front Aging Neurosci. 2009;1:3.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"827_CR64","doi-asserted-by":"publisher","first-page":"e298","DOI":"10.1038\/emm.2016.159","volume":"49","author":"YC Chung","year":"2017","unstructured":"Chung YC, Baek JY, Kim SR, et al. Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson\u2019s disease. Exp Mol Med. 2017;49(3):e298.","journal-title":"Exp Mol Med"},{"issue":"34","key":"827_CR65","doi-asserted-by":"publisher","first-page":"eadn4845","DOI":"10.1126\/sciadv.adn4845","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J, Liang Y, Meng Q, et al. Antagonism of \u03b2-arrestins in IL-4-driven microglia reactivity via the Samd4\/mTOR\/OXPHOS axis in Parkinson\u2019s disease. Sci Adv. 2024;10(34):eadn4845.","journal-title":"Sci Adv"},{"issue":"3","key":"827_CR66","doi-asserted-by":"publisher","first-page":"165615","DOI":"10.1016\/j.bbadis.2019.165615","volume":"1866","author":"CM Deus","year":"2020","unstructured":"Deus CM, Pereira SP, Cunha-Oliveira T, Pereira FB, Raimundo N, Oliveira PJ. Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson\u2019s disease patients uncovers metabolic and mitochondrial bioenergetic defects. Biochim Biophys Acta Mol Basis Dis. 2020;1866(3):165615.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"827_CR67","first-page":"1819209","volume":"2016","author":"W Haylett","year":"2016","unstructured":"Haylett W, Swart C, van der Westhuizen F, et al. Altered mitochondrial respiration and other features of mitochondrial function in Parkin-Mutant fibroblasts from Parkinson\u2019s disease patients. Parkinsons Dis. 2016;2016:1819209.","journal-title":"Parkinsons Dis"},{"key":"827_CR68","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ebiom.2018.05.007","volume":"31","author":"S Ugras","year":"2018","unstructured":"Ugras S, Daniels MJ, Fazelinia H, et al. Induction of the Immunoproteasome subunit Lmp7 links proteostasis and immunity in \u03b1-Synuclein aggregation disorders. EBioMedicine. 2018;31:307\u201319.","journal-title":"EBioMedicine"},{"issue":"18","key":"827_CR69","doi-asserted-by":"publisher","first-page":"10863","DOI":"10.3390\/ijms231810863","volume":"23","author":"T Schirinzi","year":"2022","unstructured":"Schirinzi T, Salvatori I, Zenuni H, et al. Pattern of mitochondrial respiration in peripheral blood cells of patients with Parkinson\u2019s disease. Int J Mol Sci. 2022;23(18):10863.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"827_CR70","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1242\/dmm.025684","volume":"9","author":"SJ Annesley","year":"2016","unstructured":"Annesley SJ, Lay ST, De Piazza SW, et al. Immortalized Parkinson\u2019s disease lymphocytes have enhanced mitochondrial respiratory activity. Dis Model Mech. 2016;9(11):1295\u2013305.","journal-title":"Dis Model Mech"},{"key":"827_CR71","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.redox.2013.12.026","volume":"2","author":"PA Kramer","year":"2014","unstructured":"Kramer PA, Ravi S, Chacko B, Johnson MS, Darley-Usmar VM. A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers. Redox Biol. 2014;2:206\u201310.","journal-title":"Redox Biol"},{"issue":"Pt 2","key":"827_CR72","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"552","author":"JF Turrens","year":"2003","unstructured":"Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003;552(Pt 2):335\u201344.","journal-title":"J Physiol"},{"issue":"21","key":"827_CR73","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res. 2013;8(21):2003\u201314.","journal-title":"Neural Regen Res"},{"issue":"1","key":"827_CR74","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41420-021-00491-3","volume":"7","author":"D Azzouz","year":"2021","unstructured":"Azzouz D, Khan MA, Palaniyar N. ROS induces NETosis by oxidizing DNA and initiating DNA repair. Cell Death Discovery. 2021;7(1):113.","journal-title":"Cell Death Discovery"},{"issue":"5","key":"827_CR75","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1046\/j.1471-4159.1998.71052112.x","volume":"71","author":"JP Spencer","year":"1998","unstructured":"Spencer JP, Jenner P, Daniel SE, Lees AJ, Marsden DC, Halliwell B. Conjugates of catecholamines with cysteine and GSH in Parkinson\u2019s disease: possible mechanisms of formation involving reactive oxygen species. J Neurochem. 1998;71(5):2112\u201322.","journal-title":"J Neurochem"},{"issue":"12","key":"827_CR76","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/humu.21582","volume":"32","author":"DC Angeles","year":"2011","unstructured":"Angeles DC, Gan BH, Onstead L, et al. Mutations in LRRK2 increase phosphorylation of Peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum Mutat. 2011;32(12):1390\u20137.","journal-title":"Hum Mutat"},{"issue":"6","key":"827_CR77","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1046\/j.1471-4159.2003.01954.x","volume":"86","author":"J Ehrhart","year":"2003","unstructured":"Ehrhart J, Zeevalk GD. Cooperative interaction between ascorbate and glutathione during mitochondrial impairment in mesencephalic cultures. J Neurochem. 2003;86(6):1487\u201397.","journal-title":"J Neurochem"},{"issue":"4","key":"827_CR78","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.yexcr.2009.09.014","volume":"316","author":"HY Heo","year":"2010","unstructured":"Heo HY, Park JM, Kim CH, Han BS, Kim KS, Seol W. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity. Exp Cell Res. 2010;316(4):649\u201356.","journal-title":"Exp Cell Res"},{"issue":"19","key":"827_CR79","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1093\/hmg\/ddq288","volume":"19","author":"I Irrcher","year":"2010","unstructured":"Irrcher I, Aleyasin H, Seifert EL, et al. Loss of the Parkinson\u2019s disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet. 2010;19(19):3734\u201346.","journal-title":"Hum Mol Genet"},{"issue":"23","key":"827_CR80","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1073\/pnas.1106291108","volume":"108","author":"F Billia","year":"2011","unstructured":"Billia F, Hauck L, Konecny F, Rao V, Shen J, Mak TW. PTEN-inducible kinase 1 (PINK1)\/Park6 is indispensable for normal heart function. Proc Natl Acad Sci U S A. 2011;108(23):9572\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"827_CR81","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2015.12.057","volume":"164","author":"Z Zhong","year":"2016","unstructured":"Zhong Z, Umemura A, Sanchez-Lopez E, et al. NF-\u03baB restricts inflammasome activation via elimination of damaged mitochondria. Cell. 2016;164(5):896\u2013910.","journal-title":"Cell"},{"issue":"5","key":"827_CR82","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ana.21492","volume":"64","author":"H Mortiboys","year":"2008","unstructured":"Mortiboys H, Thomas KJ, Koopman WJ, et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol. 2008;64(5):555\u201365.","journal-title":"Ann Neurol"},{"issue":"12","key":"827_CR83","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/hmg\/ddz038","volume":"28","author":"F Zambon","year":"2019","unstructured":"Zambon F, Cherubini M, Fernandes HJR, et al. Cellular \u03b1-synuclein pathology is associated with bioenergetic dysfunction in Parkinson\u2019s iPSC-derived dopamine neurons. Hum Mol Genet. 2019;28(12):2001\u201313.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"827_CR84","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/ars.2015.6343","volume":"24","author":"E Deas","year":"2016","unstructured":"Deas E, Cremades N, Angelova PR, et al. Alpha-Synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease. Antioxid Redox Signal. 2016;24(7):376\u201391.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"827_CR85","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.nbd.2011.12.015","volume":"45","author":"AM Gusdon","year":"2012","unstructured":"Gusdon AM, Zhu J, Van Houten B, Chu CT. ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol Dis. 2012;45(3):962\u201372.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"827_CR86","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0306-4522(95)00578-1","volume":"72","author":"S Hunot","year":"1996","unstructured":"Hunot S, Boissi\u00e8re F, Faucheux B, et al. Nitric oxide synthase and neuronal vulnerability in Parkinson\u2019s disease. Neuroscience. 1996;72(2):355\u201363.","journal-title":"Neuroscience"},{"issue":"6","key":"827_CR87","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1006\/mcne.2000.0914","volume":"16","author":"C Knott","year":"2000","unstructured":"Knott C, Stern G, Wilkin GP. Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and\u2013\u20092. Mol Cell Neurosci. 2000;16(6):724\u201339.","journal-title":"Mol Cell Neurosci"},{"issue":"6","key":"827_CR88","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, et al. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. Faseb J. 2005;19(6):533\u201342.","journal-title":"Faseb J"},{"key":"827_CR89","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1749-6632.2002.tb04077.x","volume":"962","author":"B Liu","year":"2002","unstructured":"Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann N Y Acad Sci. 2002;962:318\u201331.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"827_CR90","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido S, Muggeo S, Massimino L, et al. Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun. 2021;12(1):6237.","journal-title":"Nat Commun"},{"issue":"2","key":"827_CR91","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1471-4159.2006.04315.x","volume":"100","author":"MP Thomas","year":"2007","unstructured":"Thomas MP, Chartrand K, Reynolds A, Vitvitsky V, Banerjee R, Gendelman HE. Ion channel Blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson\u2019s disease. J Neurochem. 2007;100(2):503\u201319.","journal-title":"J Neurochem"},{"key":"827_CR92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1326-4-55","volume":"4","author":"SB Shaikh","year":"2009","unstructured":"Shaikh SB, Nicholson LF. Effects of chronic low dose rotenone treatment on human microglial cells. Mol Neurodegener. 2009;4:55.","journal-title":"Mol Neurodegener"},{"issue":"9","key":"827_CR93","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/aps.2016.68","volume":"37","author":"YX Yu","year":"2016","unstructured":"Yu YX, Li YP, Gao F, et al. Vitamin K2 suppresses rotenone-induced microglial activation in vitro. Acta Pharmacol Sin. 2016;37(9):1178\u201389.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"827_CR94","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira K, Haspel JA, Rathinam VA, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12(3):222\u201330.","journal-title":"Nat Immunol"},{"issue":"7329","key":"827_CR95","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469(7329):221\u20135.","journal-title":"Nature"},{"issue":"1","key":"827_CR96","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2006.01.013","volume":"23","author":"A Prigione","year":"2006","unstructured":"Prigione A, Begni B, Galbussera A, et al. Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson\u2019s disease: negative correlation with Levodopa dosage. Neurobiol Dis. 2006;23(1):36\u201343.","journal-title":"Neurobiol Dis"},{"issue":"6","key":"827_CR97","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1089\/ars.2013.5447","volume":"20","author":"CN Paiva","year":"2014","unstructured":"Paiva CN, Bozza MT. Are reactive oxygen species always detrimental to pathogens? Antioxid Redox Signal. 2014;20(6):1000\u201337.","journal-title":"Antioxid Redox Signal"},{"key":"827_CR98","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ab.2017.07.009","volume":"552","author":"LD Zorova","year":"2018","unstructured":"Zorova LD, Popkov VA, Plotnikov EY, et al. Mitochondrial membrane potential. Anal Biochem. 2018;552:50\u20139.","journal-title":"Anal Biochem"},{"issue":"5","key":"827_CR99","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.molcel.2009.02.013","volume":"33","author":"S Gandhi","year":"2009","unstructured":"Gandhi S, Wood-Kaczmar A, Yao Z, et al. PINK1-associated Parkinson\u2019s disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell. 2009;33(5):627\u201338.","journal-title":"Mol Cell"},{"issue":"5","key":"827_CR100","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4161\/auto.7.5.14684","volume":"7","author":"MK McCoy","year":"2011","unstructured":"McCoy MK, Cookson MR. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy. 2011;7(5):531\u20132.","journal-title":"Autophagy"},{"issue":"9","key":"827_CR101","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41593-022-01140-3","volume":"25","author":"ML Choi","year":"2022","unstructured":"Choi ML, Chappard A, Singh BP, et al. Pathological structural conversion of \u03b1-synuclein at the mitochondria induces neuronal toxicity. Nat Neurosci. 2022;25(9):1134\u201348.","journal-title":"Nat Neurosci"},{"issue":"1","key":"827_CR102","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12974-024-03164-x","volume":"21","author":"F Lind-Holm Mogensen","year":"2024","unstructured":"Lind-Holm Mogensen F, Sousa C, Ameli C, et al. PARK7\/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation. J Neuroinflammation. 2024;21(1):174.","journal-title":"J Neuroinflammation"},{"issue":"12","key":"827_CR103","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1093\/brain\/awac313","volume":"145","author":"D Imberechts","year":"2022","unstructured":"Imberechts D, Kinnart I, Wauters F, et al. DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy. Brain. 2022;145(12):4368\u201384.","journal-title":"Brain"},{"issue":"6","key":"827_CR104","first-page":"719","volume":"36","author":"R Qadri","year":"2018","unstructured":"Qadri R, Namdeo M, Behari M, Goyal V, Sharma S, Mukhopadhyay AK. Alterations in mitochondrial membrane potential in peripheral blood mononuclear cells in Parkinson\u2019s disease: potential for a novel biomarker. Restor Neurol Neurosci. 2018;36(6):719\u201327.","journal-title":"Restor Neurol Neurosci"},{"issue":"4","key":"827_CR105","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ. Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci. 2021;46(4):329\u201343.","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"827_CR106","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","volume":"19","author":"CH Hsieh","year":"2016","unstructured":"Hsieh CH, Shaltouki A, Gonzalez AE, et al. Functional impairment in Miro degradation and mitophagy is a shared feature in Familial and sporadic Parkinson\u2019s disease. Cell Stem Cell. 2016;19(6):709\u201324.","journal-title":"Cell Stem Cell"},{"key":"827_CR107","doi-asserted-by":"crossref","unstructured":"Singh F, Prescott AR, Rosewell P, Ball G, Reith AD, Ganley IG. Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice. Elife 2021;10.","DOI":"10.7554\/eLife.67604"},{"issue":"5","key":"827_CR108","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.stemcr.2019.03.004","volume":"12","author":"J Walter","year":"2019","unstructured":"Walter J, Bolognin S, Antony PMA, et al. Neural stem cells of Parkinson\u2019s disease patients exhibit aberrant mitochondrial morphology and functionality. Stem Cell Rep. 2019;12(5):878\u201389.","journal-title":"Stem Cell Rep"},{"issue":"10","key":"827_CR109","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5483\/BMBRep.2016.49.10.115","volume":"49","author":"MJ Kim","year":"2016","unstructured":"Kim MJ, Yoon JH, Ryu JH. Mitophagy: a balance regulator of NLRP3 inflammasome activation. BMB Rep. 2016;49(10):529\u201335.","journal-title":"BMB Rep"},{"key":"827_CR110","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2014.01.002","volume":"69","author":"W Zhao","year":"2014","unstructured":"Zhao W, Li Y, Jia L, Pan L, Li H, Du J. Atg5 deficiency-mediated mitophagy aggravates cardiac inflammation and injury in response to angiotensin II. Free Radic Biol Med. 2014;69:108\u201315.","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"827_CR111","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1080\/15548627.2020.1719723","volume":"16","author":"J Cheng","year":"2020","unstructured":"Cheng J, Liao Y, Dong Y, et al. Microglial autophagy defect causes Parkinson disease-like symptoms by accelerating inflammasome activation in mice. Autophagy. 2020;16(12):2193\u2013205.","journal-title":"Autophagy"},{"key":"827_CR112","doi-asserted-by":"publisher","first-page":"102010","DOI":"10.1016\/j.redox.2021.102010","volume":"44","author":"X Han","year":"2021","unstructured":"Han X, Xu T, Fang Q, et al. Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy. Redox Biol. 2021;44:102010.","journal-title":"Redox Biol"},{"key":"827_CR113","doi-asserted-by":"publisher","first-page":"108963","DOI":"10.1016\/j.neuropharm.2022.108963","volume":"207","author":"J Qiu","year":"2022","unstructured":"Qiu J, Chen Y, Zhuo J, et al. Urolithin A promotes mitophagy and suppresses NLRP3 inflammasome activation in lipopolysaccharide-induced BV2 microglial cells and MPTP-induced Parkinson\u2019s disease model. Neuropharmacology. 2022;207:108963.","journal-title":"Neuropharmacology"},{"key":"827_CR114","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-90-481-3471-7_11","volume":"50","author":"WC Copeland","year":"2010","unstructured":"Copeland WC. The mitochondrial DNA polymerase in health and disease. Subcell Biochem. 2010;50:211\u201322.","journal-title":"Subcell Biochem"},{"issue":"7","key":"827_CR115","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/jnen\/61.7.634","volume":"61","author":"G Gu","year":"2002","unstructured":"Gu G, Reyes PE, Golden GT, et al. Mitochondrial DNA deletions\/rearrangements in Parkinson disease and related neurodegenerative disorders. J Neuropathol Exp Neurol. 2002;61(7):634\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"827_CR116","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neurobiolaging.2017.10.024","volume":"63","author":"GS Nido","year":"2018","unstructured":"Nido GS, D\u00f6lle C, Fl\u00f8nes I, et al. Ultradeep mapping of neuronal mitochondrial deletions in Parkinson\u2019s disease. Neurobiol Aging. 2018;63:120\u20137.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"827_CR117","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia Nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38(5):515\u20137.","journal-title":"Nat Genet"},{"issue":"711","key":"827_CR118","doi-asserted-by":"publisher","first-page":"eabo1557","DOI":"10.1126\/scitranslmed.abo1557","volume":"15","author":"R Qi","year":"2023","unstructured":"Qi R, Sammler E, Gonzalez-Hunt CP, et al. A blood-based marker of mitochondrial DNA damage in Parkinson\u2019s disease. Sci Transl Med. 2023;15(711):eabo1557.","journal-title":"Sci Transl Med"},{"issue":"17","key":"827_CR119","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/ars.2015.6407","volume":"23","author":"K Nakahira","year":"2015","unstructured":"Nakahira K, Hisata S, Choi AM. The roles of mitochondrial Damage-Associated molecular patterns in diseases. Antioxid Redox Signal. 2015;23(17):1329\u201350.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"827_CR120","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1042\/BST20221010","volume":"51","author":"G Zanini","year":"2023","unstructured":"Zanini G, Selleri V, Lopez Domenech S, et al. Mitochondrial DNA as inflammatory DAMP: a warning of an aging immune system? Biochem Soc Trans. 2023;51(2):735\u201345.","journal-title":"Biochem Soc Trans"},{"issue":"15","key":"827_CR121","doi-asserted-by":"publisher","first-page":"e2118819119","DOI":"10.1073\/pnas.2118819119","volume":"119","author":"JT Hinkle","year":"2022","unstructured":"Hinkle JT, Patel J, Panicker N, et al. STING mediates neurodegeneration and neuroinflammation in nigrostriatal \u03b1-synucleinopathy. Proc Natl Acad Sci U S A. 2022;119(15):e2118819119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"827_CR122","doi-asserted-by":"crossref","unstructured":"Hancock-Cerutti W, Wu Z, Xu P et al. ER-lysosome lipid transfer protein VPS13C\/PARK23 prevents aberrant mtDNA-dependent STING signaling. J Cell Biol 2022;221(7).","DOI":"10.1083\/jcb.202106046"},{"issue":"10","key":"827_CR123","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1083\/jcb.201807019","volume":"217","author":"N Kumar","year":"2018","unstructured":"Kumar N, Leonzino M, Hancock-Cerutti W, et al. VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. J Cell Biol. 2018;217(10):3625\u201339.","journal-title":"J Cell Biol"},{"issue":"6","key":"827_CR124","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/mds.26562","volume":"31","author":"T Moors","year":"2016","unstructured":"Moors T, Paciotti S, Chiasserini D, et al. Lysosomal dysfunction and \u03b1-Synuclein aggregation in Parkinson\u2019s disease: diagnostic links. Mov Disord. 2016;31(6):791\u2013801.","journal-title":"Mov Disord"},{"issue":"7","key":"827_CR125","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1073\/pnas.1520335113","volume":"113","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli JR, Zunke F, Isacson O, Studer L, Krainc D. \u03b1-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc Natl Acad Sci U S A. 2016;113(7):1931\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"827_CR126","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3233\/JPD-202138","volume":"10","author":"ML Erb","year":"2020","unstructured":"Erb ML, Moore DJ. LRRK2 and the endolysosomal system in Parkinson\u2019s disease. J Parkinsons Dis. 2020;10(4):1271\u201391.","journal-title":"J Parkinsons Dis"},{"key":"827_CR127","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fnagi.2020.00097","volume":"12","author":"M Avenali","year":"2020","unstructured":"Avenali M, Blandini F, Cerri S. Glucocerebrosidase defects as a major risk factor for Parkinson\u2019s disease. Front Aging Neurosci. 2020;12:97.","journal-title":"Front Aging Neurosci"},{"key":"827_CR128","doi-asserted-by":"crossref","unstructured":"Navarro-Romero A, Montpey\u00f3 M, Martinez-Vicente M. The Emerging Role of the Lysosome in Parkinson\u2019s Disease. Cells 2020;9(11).","DOI":"10.3390\/cells9112399"},{"issue":"5","key":"827_CR129","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1042\/BST20120119","volume":"40","author":"N Dzamko","year":"2012","unstructured":"Dzamko N, Halliday GM. An emerging role for LRRK2 in the immune system. Biochem Soc Trans. 2012;40(5):1134\u20139.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"827_CR130","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/mds.28375","volume":"36","author":"S Mullin","year":"2021","unstructured":"Mullin S, Stokholm MG, Hughes D, et al. Brain microglial activation increased in glucocerebrosidase (GBA) mutation carriers without Parkinson\u2019s disease. Mov Disord. 2021;36(3):774\u20139.","journal-title":"Mov Disord"},{"issue":"7330","key":"827_CR131","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature09782","volume":"469","author":"B Levine","year":"2011","unstructured":"Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature. 2011;469(7330):323\u201335.","journal-title":"Nature"},{"issue":"1","key":"827_CR132","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15548627.2023.2247300","volume":"20","author":"Y Feng","year":"2024","unstructured":"Feng Y, Chen Y, Wu X, et al. Interplay of energy metabolism and autophagy. Autophagy. 2024;20(1):4\u201314.","journal-title":"Autophagy"},{"key":"827_CR133","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/978-981-15-0602-4_27","volume":"1206","author":"B Cui","year":"2019","unstructured":"Cui B, Lin H, Yu J, Yu J, Hu Z. Autophagy and the immune response. Adv Exp Med Biol. 2019;1206:595\u2013634.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"827_CR134","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F, et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol. 1997;12(1):25\u201331.","journal-title":"Histol Histopathol"},{"issue":"1","key":"827_CR135","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/mds.27895","volume":"35","author":"G Bellomo","year":"2020","unstructured":"Bellomo G, Paciotti S, Gatticchi L, Parnetti L. The vicious cycle between \u03b1-synuclein aggregation and autophagic-lysosomal dysfunction. Mov Disord. 2020;35(1):34\u201344.","journal-title":"Mov Disord"},{"issue":"8","key":"827_CR136","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","volume":"432","author":"X Hou","year":"2020","unstructured":"Hou X, Watzlawik JO, Fiesel FC, Springer W. Autophagy in Parkinson\u2019s disease. J Mol Biol. 2020;432(8):2651\u201372.","journal-title":"J Mol Biol"},{"issue":"12","key":"827_CR137","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","volume":"67","author":"L Alvarez-Erviti","year":"2010","unstructured":"Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol. 2010;67(12):1464\u201372.","journal-title":"Arch Neurol"},{"issue":"3","key":"827_CR138","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","volume":"35","author":"L Chen","year":"2015","unstructured":"Chen L, Xie Z, Turkson S, Zhuang X. A53T human \u03b1-synuclein overexpression in Transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration. J Neurosci. 2015;35(3):890\u2013905.","journal-title":"J Neurosci"},{"issue":"3","key":"827_CR139","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","volume":"105","author":"ED Plowey","year":"2008","unstructured":"Plowey ED, Cherra SJ 3rd, Liu YJ, Chu CT. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem. 2008;105(3):1048\u201356.","journal-title":"J Neurochem"},{"issue":"8","key":"827_CR140","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/15548627.2016.1179401","volume":"12","author":"B Wang","year":"2016","unstructured":"Wang B, Cai Z, Tao K, et al. Essential control of mitochondrial morphology and function by chaperone-mediated autophagy through degradation of PARK7. Autophagy. 2016;12(8):1215\u201328.","journal-title":"Autophagy"},{"key":"827_CR141","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1038\/ncomms4828","volume":"5","author":"E Zavodszky","year":"2014","unstructured":"Zavodszky E, Seaman MN, Moreau K, et al. Mutation in VPS35 associated with Parkinson\u2019s disease impairs WASH complex association and inhibits autophagy. Nat Commun. 2014;5:3828.","journal-title":"Nat Commun"},{"issue":"3","key":"827_CR142","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","volume":"372","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee SJ. Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun. 2008;372(3):423\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"827_CR143","doi-asserted-by":"publisher","first-page":"e13522","DOI":"10.1111\/acel.13522","volume":"20","author":"HY Tu","year":"2021","unstructured":"Tu HY, Yuan BS, Hou XO, et al. \u03b1-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson\u2019s disease. Aging Cell. 2021;20(12):e13522.","journal-title":"Aging Cell"},{"issue":"5","key":"827_CR144","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jnc.14222","volume":"143","author":"Y Nash","year":"2017","unstructured":"Nash Y, Schmukler E, Trudler D, Pinkas-Kramarski R, Frenkel D. DJ-1 deficiency impairs autophagy and reduces alpha-synuclein phagocytosis by microglia. J Neurochem. 2017;143(5):584\u201394.","journal-title":"J Neurochem"},{"key":"827_CR145","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1073\/pnas.2023418118","volume":"118","author":"Y Xu","year":"2021","unstructured":"Xu Y, Propson NE, Du S, Xiong W, Zheng H. Autophagy deficiency modulates microglial lipid homeostasis and aggravates Tau pathology and spreading. Proc Natl Acad Sci U S A. 2021;118:27.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"827_CR146","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40478-019-0836-x","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson MX, Sengupta M, Trojanowski JQ, Lee VMY. Alzheimer\u2019s disease Tau is a prominent pathology in LRRK2 Parkinson\u2019s disease. Acta Neuropathol Commun. 2019;7(1):183.","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"827_CR147","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/atm.2018.04.23","volume":"6","author":"YL Gao","year":"2018","unstructured":"Gao YL, Wang N, Sun FR, Cao XP, Zhang W, Yu JT. Tau in neurodegenerative disease. Ann Transl Med. 2018;6(10):175.","journal-title":"Ann Transl Med"},{"key":"827_CR148","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.bbi.2020.10.010","volume":"91","author":"Y Qin","year":"2021","unstructured":"Qin Y, Qiu J, Wang P, et al. Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson\u2019s disease. Brain Behav Immun. 2021;91:324\u201338.","journal-title":"Brain Behav Immun"},{"key":"827_CR149","doi-asserted-by":"crossref","unstructured":"Vavilova JD, Boyko AA, Troyanova NI et al. Alterations in proteostasis system components in peripheral blood mononuclear cells in Parkinson disease: focusing on the HSP70 and p62 levels. Biomolecules 2022;12(4).","DOI":"10.3390\/biom12040493"},{"key":"827_CR150","doi-asserted-by":"publisher","first-page":"144454","DOI":"10.1016\/j.gene.2020.144454","volume":"738","author":"S El Haddad","year":"2020","unstructured":"El Haddad S, Serrano A, Moal F, et al. Disturbed expression of autophagy genes in blood of Parkinson\u2019s disease patients. Gene. 2020;738:144454.","journal-title":"Gene"},{"key":"827_CR151","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.brainres.2011.04.013","volume":"1394","author":"G Wu","year":"2011","unstructured":"Wu G, Wang X, Feng X, et al. Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson\u2019s disease. Brain Res. 2011;1394:105\u201311.","journal-title":"Brain Res"},{"key":"827_CR152","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neurobiolaging.2017.11.006","volume":"63","author":"Y Miki","year":"2018","unstructured":"Miki Y, Shimoyama S, Kon T, et al. Alteration of autophagy-related proteins in peripheral blood mononuclear cells of patients with Parkinson\u2019s disease. Neurobiol Aging. 2018;63:33\u201343.","journal-title":"Neurobiol Aging"},{"key":"827_CR153","doi-asserted-by":"publisher","first-page":"201221","DOI":"10.1002\/cptx.11","volume":"69","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Singh R, Aschner M. Methods for the detection of autophagy in mammalian cells. Curr Protoc Toxicol. 2016;69:201221\u20136.","journal-title":"Curr Protoc Toxicol"},{"issue":"1","key":"827_CR154","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/jnr.24092","volume":"96","author":"AG Erustes","year":"2018","unstructured":"Erustes AG, Stefani FY, Terashima JY, et al. Overexpression of \u03b1-synuclein in an astrocyte cell line promotes autophagy Inhibition and apoptosis. J Neurosci Res. 2018;96(1):160\u201371.","journal-title":"J Neurosci Res"},{"issue":"1","key":"827_CR155","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2010.04.022","volume":"477","author":"A Prigione","year":"2010","unstructured":"Prigione A, Piazza F, Brighina L, et al. Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease. Neurosci Lett. 2010;477(1):6\u201310.","journal-title":"Neurosci Lett"},{"issue":"2","key":"827_CR156","doi-asserted-by":"publisher","first-page":"25","DOI":"10.14802\/jmd.10008","volume":"3","author":"U Kumari","year":"2010","unstructured":"Kumari U, Tan EK. Leucine-rich repeat kinase 2-linked Parkinson\u2019s disease: clinical and molecular findings. J Mov Disord. 2010;3(2):25\u201331.","journal-title":"J Mov Disord"},{"issue":"6","key":"827_CR157","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1042\/BST20180463","volume":"47","author":"RL Wallings","year":"2019","unstructured":"Wallings RL, Tansey MG. LRRK2 regulation of immune-pathways and inflammatory disease. Biochem Soc Trans. 2019;47(6):1581\u201395.","journal-title":"Biochem Soc Trans"},{"key":"827_CR158","doi-asserted-by":"crossref","unstructured":"Steger M, Tonelli F, Ito G et al. Phosphoproteomics reveals that Parkinson\u2019s disease kinase LRRK2 regulates a subset of Rab GTPases. Elife 2016;5.","DOI":"10.7554\/eLife.12813"},{"issue":"4","key":"827_CR159","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/21541248.2016.1235004","volume":"9","author":"OV Vieira","year":"2018","unstructured":"Vieira OV. Rab3a and Rab10 are regulators of lysosome exocytosis and plasma membrane repair. Small GTPases. 2018;9(4):349\u201351.","journal-title":"Small GTPases"},{"issue":"2","key":"827_CR160","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1600-0854.2009.01013.x","volume":"11","author":"CM Cardoso","year":"2010","unstructured":"Cardoso CM, Jordao L, Vieira OV. Rab10 regulates phagosome maturation and its overexpression rescues Mycobacterium-containing phagosomes maturation. Traffic. 2010;11(2):221\u201335.","journal-title":"Traffic"},{"issue":"11","key":"827_CR161","doi-asserted-by":"publisher","first-page":"a022616","DOI":"10.1101\/cshperspect.a022616","volume":"6","author":"A Wandinger-Ness","year":"2014","unstructured":"Wandinger-Ness A, Zerial M. Rab proteins and the compartmentalization of the endosomal system. Cold Spring Harb Perspect Biol. 2014;6(11):a022616.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"827_CR162","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4161\/cib.3.5.12286","volume":"3","author":"L Parisiadou","year":"2010","unstructured":"Parisiadou L, Cai H. LRRK2 function on actin and microtubule dynamics in Parkinson disease. Commun Integr Biol. 2010;3(5):396\u2013400.","journal-title":"Commun Integr Biol"},{"key":"827_CR163","doi-asserted-by":"crossref","unstructured":"Bonet-Ponce L, Beilina A, Williamson CD et al. LRRK2 mediates tubulation and vesicle sorting from lysosomes. Sci Adv 2020;6(46).","DOI":"10.1126\/sciadv.abb2454"},{"issue":"11","key":"827_CR164","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1523\/JNEUROSCI.4566-11.2012","volume":"32","author":"Y Xiong","year":"2012","unstructured":"Xiong Y, Yuan C, Chen R, Dawson TM, Dawson VL. ArfGAP1 is a GTPase activating protein for LRRK2: reciprocal regulation of ArfGAP1 by LRRK2. J Neurosci. 2012;32(11):3877\u201386.","journal-title":"J Neurosci"},{"issue":"5","key":"827_CR165","doi-asserted-by":"publisher","first-page":"107614","DOI":"10.1016\/j.celrep.2020.107614","volume":"31","author":"A Beilina","year":"2020","unstructured":"Beilina A, Bonet-Ponce L, Kumaran R, et al. The Parkinson\u2019s disease protein LRRK2 interacts with the GARP complex to promote retrograde transport to the trans-Golgi network. Cell Rep. 2020;31(5):107614.","journal-title":"Cell Rep"},{"issue":"20","key":"827_CR166","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.15252\/embj.201487807","volume":"33","author":"HJ Cho","year":"2014","unstructured":"Cho HJ, Yu J, Xie C, et al. Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. Embo J. 2014;33(20):2314\u201331.","journal-title":"Embo J"},{"key":"827_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-015-0066-z","volume":"11","author":"E Belluzzi","year":"2016","unstructured":"Belluzzi E, Gonnelli A, Cirnaru MD, et al. LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate. Mol Neurodegener. 2016;11:1.","journal-title":"Mol Neurodegener"},{"key":"827_CR168","doi-asserted-by":"publisher","first-page":"102064","DOI":"10.1016\/j.omtn.2023.102064","volume":"34","author":"RL Wallings","year":"2023","unstructured":"Wallings RL, Mark JR, Staley HA, et al. ASO-mediated knockdown or kinase Inhibition of G2019S-Lrrk2 modulates lysosomal tubule-associated antigen presentation in macrophages. Mol Ther Nucleic Acids. 2023;34:102064.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7165","key":"827_CR169","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/nature06216","volume":"449","author":"A Hierro","year":"2007","unstructured":"Hierro A, Rojas AL, Rojas R, et al. Functional architecture of the retromer cargo-recognition complex. Nature. 2007;449(7165):1063\u20137.","journal-title":"Nature"},{"issue":"1","key":"827_CR170","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","volume":"89","author":"A Zimprich","year":"2011","unstructured":"Zimprich A, Benet-Pag\u00e8s A, Struhal W, et al. A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet. 2011;89(1):168\u201375.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"827_CR171","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","volume":"89","author":"C Vilari\u00f1o-G\u00fcell","year":"2011","unstructured":"Vilari\u00f1o-G\u00fcell C, Wider C, Ross OA, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet. 2011;89(1):162\u20137.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"827_CR172","doi-asserted-by":"publisher","first-page":"e13347","DOI":"10.1111\/acel.13347","volume":"20","author":"M Niu","year":"2021","unstructured":"Niu M, Zhao F, Bondelid K, et al. VPS35 D620N knockin mice recapitulate Cardinal features of Parkinson\u2019s disease. Aging Cell. 2021;20(5):e13347.","journal-title":"Aging Cell"},{"issue":"12","key":"827_CR173","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1073\/pnas.1814909116","volume":"116","author":"X Chen","year":"2019","unstructured":"Chen X, Kordich JK, Williams ET, et al. Parkinson\u2019s disease-linked D620N VPS35 knockin mice manifest Tau neuropathology and dopaminergic neurodegeneration. Proc Natl Acad Sci U S A. 2019;116(12):5765\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"827_CR174","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1042\/BCJ20180248","volume":"475","author":"R Mir","year":"2018","unstructured":"Mir R, Tonelli F, Lis P, et al. The Parkinson\u2019s disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human. Biochem J. 2018;475(11):1861\u201383.","journal-title":"Biochem J"},{"issue":"12","key":"827_CR175","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/tra.12451","volume":"17","author":"J Yin","year":"2016","unstructured":"Yin J, Liu X, He Q, Zhou L, Yuan Z, Zhao S. Vps35-dependent recycling of Trem2 regulates microglial function. Traffic. 2016;17(12):1286\u201396.","journal-title":"Traffic"},{"issue":"50","key":"827_CR176","doi-asserted-by":"publisher","first-page":"eadj1205","DOI":"10.1126\/sciadv.adj1205","volume":"9","author":"P Pal","year":"2023","unstructured":"Pal P, Taylor M, Lam PY, et al. Parkinson\u2019s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B. Sci Adv. 2023;9(50):eadj1205.","journal-title":"Sci Adv"},{"issue":"1","key":"827_CR177","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41531-023-00609-7","volume":"9","author":"M Bu","year":"2023","unstructured":"Bu M, Follett J, Deng I, et al. Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice. NPJ Parkinsons Dis. 2023;9(1):167.","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"827_CR178","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s12035-018-1090-0","volume":"56","author":"TE Moors","year":"2019","unstructured":"Moors TE, Paciotti S, Ingrassia A, et al. Characterization of brain lysosomal activities in GBA-Related and sporadic Parkinson\u2019s disease and dementia with lewy bodies. Mol Neurobiol. 2019;56(2):1344\u201355.","journal-title":"Mol Neurobiol"},{"key":"827_CR179","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.nbd.2017.11.006","volume":"110","author":"MP Nelson","year":"2018","unstructured":"Nelson MP, Boutin M, Tse TE, et al. The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson\u2019s disease brain in association with the pathologic accumulation of alpha-synuclein. Neurobiol Dis. 2018;110:68\u201381.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"827_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","volume":"13","author":"SP Yun","year":"2018","unstructured":"Yun SP, Kim D, Kim S, et al. \u03b1-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism. Mol Neurodegener. 2018;13(1):1.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"827_CR181","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40035-023-00363-z","volume":"12","author":"A Drobny","year":"2023","unstructured":"Drobny A, Boros FA, Balta D, et al. Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models. Transl Neurodegener. 2023;12(1):31.","journal-title":"Transl Neurodegener"},{"issue":"31","key":"827_CR182","doi-asserted-by":"publisher","first-page":"e2303789120","DOI":"10.1073\/pnas.2303789120","volume":"120","author":"N Yadavalli","year":"2023","unstructured":"Yadavalli N, Ferguson SM. LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor Inhibition. Proc Natl Acad Sci U S A. 2023;120(31):e2303789120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"827_CR183","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.1093\/hmg\/ddv314","volume":"24","author":"AG Henry","year":"2015","unstructured":"Henry AG, Aghamohammadzadeh S, Samaroo H, et al. Pathogenic LRRK2 mutations, through increased kinase activity, produce enlarged lysosomes with reduced degradative capacity and increase ATP13A2 expression. Hum Mol Genet. 2015;24(21):6013\u201328.","journal-title":"Hum Mol Genet"},{"issue":"S4","key":"827_CR184","doi-asserted-by":"publisher","first-page":"e069393","DOI":"10.1002\/alz.069393","volume":"18","author":"MK Karabova","year":"2022","unstructured":"Karabova MK, Cowley SA, James WS. The role of human microglia and microglial LRRK2 in Tau pathogenesis. Alzheimer\u2019s Dement. 2022;18(S4):e069393.","journal-title":"Alzheimer\u2019s Dement"},{"key":"827_CR185","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-physiol-012110-142317","volume":"74","author":"JA Mindell","year":"2012","unstructured":"Mindell JA. Lysosomal acidification mechanisms. Annu Rev Physiol. 2012;74:69\u201386.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"827_CR186","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40035-023-00362-0","volume":"12","author":"CH Lo","year":"2023","unstructured":"Lo CH, Zeng J. Defective lysosomal acidification: a new prognostic marker and therapeutic target for neurodegenerative diseases. Transl Neurodegener. 2023;12(1):29.","journal-title":"Transl Neurodegener"},{"issue":"24","key":"827_CR187","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.1112368109","volume":"109","author":"B Dehay","year":"2012","unstructured":"Dehay B, Ramirez A, Martinez-Vicente M, et al. Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc Natl Acad Sci U S A. 2012;109(24):9611\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"827_CR188","doi-asserted-by":"crossref","unstructured":"Di Maio R, Hoffman EK, Rocha EM et al. LRRK2 activation in idiopathic Parkinson\u2019s disease. Sci Transl Med 2018;10(451).","DOI":"10.1126\/scitranslmed.aar5429"},{"key":"827_CR189","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","volume":"111","author":"J Schapansky","year":"2018","unstructured":"Schapansky J, Khasnavis S, DeAndrade MP, et al. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble \u03b1-synuclein in neurons. Neurobiol Dis. 2018;111:26\u201335.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"827_CR190","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.1038\/s41598-017-09362-3","volume":"7","author":"W Haenseler","year":"2017","unstructured":"Haenseler W, Zambon F, Lee H, et al. Excess \u03b1-synuclein compromises phagocytosis in iPSC-derived macrophages. Sci Rep. 2017;7(1):9003.","journal-title":"Sci Rep"},{"key":"827_CR191","doi-asserted-by":"publisher","first-page":"645244","DOI":"10.3389\/fncel.2021.645244","volume":"15","author":"KE Campagno","year":"2021","unstructured":"Campagno KE, Mitchell CH. The P2X(7) Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis. Front Cell Neurosci. 2021;15:645244.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"827_CR192","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-023-02568-y","volume":"145","author":"F Filipello","year":"2023","unstructured":"Filipello F, You SF, Mirfakhar FS, et al. Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation. Acta Neuropathol. 2023;145(6):749\u201372.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"827_CR193","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jalz.2014.12.009","volume":"11","author":"CM Lill","year":"2015","unstructured":"Lill CM, Rengmark A, Pihlstr\u00f8m L, et al. The role of TREM2 R47H as a risk factor for Alzheimer\u2019s disease, frontotemporal Lobar degeneration, amyotrophic lateral sclerosis, and Parkinson\u2019s disease. Alzheimers Dement. 2015;11(12):1407\u201316.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"827_CR194","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10072-015-2274-2","volume":"36","author":"Y Lu","year":"2015","unstructured":"Lu Y, Liu W, Wang X. TREM2 variants and risk of Alzheimer\u2019s disease: a meta-analysis. Neurol Sci. 2015;36(10):1881\u20138.","journal-title":"Neurol Sci"},{"key":"827_CR195","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu S, Mullen B, Baker M, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease. Mol Neurodegener. 2013;8:19.","journal-title":"Mol Neurodegener"},{"issue":"7","key":"827_CR196","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1007\/s12035-015-9416-7","volume":"53","author":"G Liu","year":"2016","unstructured":"Liu G, Liu Y, Jiang Q, et al. Convergent genetic and expression datasets highlight TREM2 in Parkinson\u2019s disease susceptibility. Mol Neurobiol. 2016;53(7):4931\u20138.","journal-title":"Mol Neurobiol"},{"key":"827_CR197","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.parkreldis.2015.11.026","volume":"23","author":"D Mengel","year":"2016","unstructured":"Mengel D, Thelen M, Balzer-Geldsetzer M, et al. TREM2 rare variant p.R47H is not associated with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2016;23:109\u201311.","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"827_CR198","doi-asserted-by":"publisher","first-page":"12164","DOI":"10.1096\/fj.201900992R","volume":"33","author":"Y Guo","year":"2019","unstructured":"Guo Y, Wei X, Yan H, et al. TREM2 deficiency aggravates \u03b1-synuclein-induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models. Faseb J. 2019;33(11):12164\u201374.","journal-title":"Faseb J"},{"issue":"1","key":"827_CR199","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.immuni.2023.12.002","volume":"57","author":"E Tagliatti","year":"2024","unstructured":"Tagliatti E, Desiato G, Mancinelli S, et al. Trem2 expression in microglia is required to maintain normal neuronal bioenergetics during development. Immunity. 2024;57(1):86\u2013e105109.","journal-title":"Immunity"},{"issue":"11","key":"827_CR200","doi-asserted-by":"publisher","first-page":"e2121609119","DOI":"10.1073\/pnas.2121609119","volume":"119","author":"RT Vest","year":"2022","unstructured":"Vest RT, Chou CC, Zhang H, et al. Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration. Proc Natl Acad Sci U S A. 2022;119(11):e2121609119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"827_CR201","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med. 2009;361(17):1651\u201361.","journal-title":"N Engl J Med"},{"issue":"6","key":"827_CR202","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","volume":"78","author":"M Anheim","year":"2012","unstructured":"Anheim M, Elbaz A, Lesage S, et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology. 2012;78(6):417\u201320.","journal-title":"Neurology"},{"issue":"29","key":"827_CR203","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","volume":"36","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli JR, Zunke F, Tsunemi T, et al. Activation of \u03b2-Glucocerebrosidase reduces pathological \u03b1-Synuclein and restores lysosomal function in Parkinson\u2019s patient midbrain neurons. J Neurosci. 2016;36(29):7693\u2013706.","journal-title":"J Neurosci"},{"issue":"6","key":"827_CR204","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/ars.2015.6307","volume":"23","author":"EM Rocha","year":"2015","unstructured":"Rocha EM, Smith GA, Park E, et al. Sustained systemic glucocerebrosidase Inhibition induces brain \u03b1-Synuclein aggregation, microglia and complement C1q activation in mice. Antioxid Redox Signal. 2015;23(6):550\u201364.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"827_CR205","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ymgme.2013.12.003","volume":"111","author":"EI Ginns","year":"2014","unstructured":"Ginns EI, Mak SK, Ko N, et al. Neuroinflammation and \u03b1-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction. Mol Genet Metab. 2014;111(2):152\u201362.","journal-title":"Mol Genet Metab"},{"issue":"14","key":"827_CR206","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1093\/hmg\/ddx120","volume":"26","author":"FN Soria","year":"2017","unstructured":"Soria FN, Engeln M, Martinez-Vicente M, et al. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration. Hum Mol Genet. 2017;26(14):2603\u201315.","journal-title":"Hum Mol Genet"},{"key":"827_CR207","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nbd.2018.12.001","volume":"124","author":"L Mus","year":"2019","unstructured":"Mus L, Siani F, Giuliano C, Ghezzi C, Cerri S, Blandini F. Development and biochemical characterization of a mouse model of Parkinson\u2019s disease bearing defective glucocerebrosidase activity. Neurobiol Dis. 2019;124:289\u201396.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"827_CR208","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/mds.27994","volume":"35","author":"A Sanyal","year":"2020","unstructured":"Sanyal A, DeAndrade MP, Novis HS, et al. Lysosome and inflammatory defects in GBA1-Mutant astrocytes are normalized by LRRK2 Inhibition. Mov Disord. 2020;35(5):760\u201373.","journal-title":"Mov Disord"},{"issue":"1","key":"827_CR209","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12974-021-02272-2","volume":"18","author":"E Brunialti","year":"2021","unstructured":"Brunialti E, Villa A, Mekhaeil M, et al. Inhibition of microglial \u03b2-glucocerebrosidase hampers the microglia-mediated antioxidant and protective response in neurons. J Neuroinflammation. 2021;18(1):220.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"827_CR210","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41531-022-00354-3","volume":"8","author":"M Kedariti","year":"2022","unstructured":"Kedariti M, Frattini E, Baden P, et al. LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):92.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"827_CR211","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1038\/s41467-019-13413-w","volume":"10","author":"D Ysselstein","year":"2019","unstructured":"Ysselstein D, Nguyen M, Young TJ, et al. LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients. Nat Commun. 2019;10(1):5570.","journal-title":"Nat Commun"},{"issue":"1","key":"827_CR212","doi-asserted-by":"publisher","first-page":"15446","DOI":"10.1038\/s41598-018-33921-x","volume":"8","author":"F Atashrazm","year":"2018","unstructured":"Atashrazm F, Hammond D, Perera G, et al. Reduced glucocerebrosidase activity in monocytes from patients with Parkinson\u2019s disease. Sci Rep. 2018;8(1):15446.","journal-title":"Sci Rep"},{"issue":"1","key":"827_CR213","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/acel.12409","volume":"15","author":"E Aflaki","year":"2016","unstructured":"Aflaki E, Moaven N, Borger DK, et al. Lysosomal storage and impaired autophagy lead to inflammasome activation in gaucher macrophages. Aging Cell. 2016;15(1):77\u201388.","journal-title":"Aging Cell"},{"issue":"Pt 9","key":"827_CR214","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"RN Alcalay","year":"2015","unstructured":"Alcalay RN, Levy OA, Waters CC, et al. Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations. Brain. 2015;138(Pt 9):2648\u201358.","journal-title":"Brain"},{"key":"827_CR215","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2015.12.002","volume":"23","author":"HJ Kim","year":"2016","unstructured":"Kim HJ, Jeon B, Song J, Lee WW, Park H, Shin CW. Leukocyte glucocerebrosidase and \u03b2-hexosaminidase activity in sporadic and genetic Parkinson disease. Parkinsonism Relat Disord. 2016;23:99\u2013101.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"827_CR216","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/gte.1997.1.5","volume":"1","author":"GA Grabowski","year":"1997","unstructured":"Grabowski GA. Gaucher disease: gene frequencies and genotype\/phenotype correlations. Genet Test. 1997;1(1):5\u201312.","journal-title":"Genet Test"},{"issue":"3","key":"827_CR217","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1016\/S0021-9258(17)42166-1","volume":"269","author":"ME Grace","year":"1994","unstructured":"Grace ME, Newman KM, Scheinker V, Berg-Fussman A, Grabowski GA. Analysis of human acid beta-glucosidase by site-directed mutagenesis and heterologous expression. J Biol Chem. 1994;269(3):2283\u201391.","journal-title":"J Biol Chem"},{"issue":"3","key":"827_CR218","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14(3):176.","journal-title":"Cell Death Dis"},{"key":"827_CR219","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1038\/ncomms6659","volume":"5","author":"D Vilchez","year":"2014","unstructured":"Vilchez D, Saez I, Dillin A. The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun. 2014;5:5659.","journal-title":"Nat Commun"},{"issue":"14","key":"827_CR220","doi-asserted-by":"publisher","first-page":"5396","DOI":"10.1074\/jbc.TM117.000893","volume":"294","author":"EA Moehle","year":"2019","unstructured":"Moehle EA, Shen K, Dillin A. Mitochondrial proteostasis in the context of cellular and organismal health and aging. J Biol Chem. 2019;294(14):5396\u2013407.","journal-title":"J Biol Chem"},{"key":"827_CR221","doi-asserted-by":"crossref","unstructured":"Jadiya P, Tomar D. Mitochondrial protein quality control mechanisms. Genes (Basel) 2020;11(5).","DOI":"10.3390\/genes11050563"},{"issue":"1","key":"827_CR222","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KS McNaught","year":"2003","unstructured":"McNaught KS, Belizaire R, Isacson O, Jenner P, Olanow CW. Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol. 2003;179(1):38\u201346.","journal-title":"Exp Neurol"},{"issue":"3","key":"827_CR223","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0304-3940(00)01701-8","volume":"297","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Jenner P. Proteasomal function is impaired in substantia Nigra in Parkinson\u2019s disease. Neurosci Lett. 2001;297(3):191\u20134.","journal-title":"Neurosci Lett"},{"issue":"1","key":"827_CR224","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2183\/pjab.85.12","volume":"85","author":"K Tanaka","year":"2009","unstructured":"Tanaka K. The proteasome: overview of structure and functions. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(1):12\u201336.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"827_CR225","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1038\/srep05896","volume":"4","author":"S Maharjan","year":"2014","unstructured":"Maharjan S, Oku M, Tsuda M, Hoseki J, Sakai Y. Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome Inhibition. Sci Rep. 2014;4:5896.","journal-title":"Sci Rep"},{"issue":"1","key":"827_CR226","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","volume":"8","author":"C McKinnon","year":"2020","unstructured":"McKinnon C, De Snoo ML, Gondard E, et al. Early-onset impairment of the ubiquitin-proteasome system in dopaminergic neurons caused by \u03b1-synuclein. Acta Neuropathol Commun. 2020;8(1):17.","journal-title":"Acta Neuropathol Commun"},{"issue":"10","key":"827_CR227","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/00001756-200007140-00004","volume":"11","author":"P Wintermeyer","year":"2000","unstructured":"Wintermeyer P, Kr\u00fcger R, Kuhn W, et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson\u2019s disease patients. NeuroReport. 2000;11(10):2079\u201382.","journal-title":"NeuroReport"},{"issue":"9","key":"827_CR228","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","volume":"20","author":"NC Chan","year":"2011","unstructured":"Chan NC, Salazar AM, Pham AH, et al. Broad activation of the ubiquitin-proteasome system by parkin is critical for mitophagy. Hum Mol Genet. 2011;20(9):1726\u201337.","journal-title":"Hum Mol Genet"},{"key":"827_CR229","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","volume":"1326","author":"S Bukhatwa","year":"2010","unstructured":"Bukhatwa S, Zeng BY, Rose S, Jenner P. A comparison of changes in proteasomal subunit expression in the substantia Nigra in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. Brain Res. 2010;1326:174\u201383.","journal-title":"Brain Res"},{"issue":"3","key":"827_CR230","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0304-3940(02)00296-3","volume":"326","author":"KS McNaught","year":"2002","unstructured":"McNaught KS, Belizaire R, Jenner P, Olanow CW, Isacson O. Selective loss of 20S proteasome alpha-subunits in the substantia Nigra Pars compacta in Parkinson\u2019s disease. Neurosci Lett. 2002;326(3):155\u20138.","journal-title":"Neurosci Lett"},{"key":"827_CR231","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.parkreldis.2016.01.001","volume":"24","author":"KH Chang","year":"2016","unstructured":"Chang KH, Lee-Chen GJ, Wu YR, et al. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson\u2019s disease. Parkinsonism Relat Disord. 2016;24:81\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"827_CR232","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","volume":"22","author":"R Betarbet","year":"2006","unstructured":"Betarbet R, Canet-Aviles RM, Sherer TB, et al. Intersecting pathways to neurodegeneration in Parkinson\u2019s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis. 2006;22(2):404\u201320.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"827_CR233","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1111\/j.1460-9568.2006.04718.x","volume":"23","author":"BY Zeng","year":"2006","unstructured":"Zeng BY, Iravani MM, Lin ST, et al. MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome. Eur J Neurosci. 2006;23(7):1766\u201374.","journal-title":"Eur J Neurosci"},{"issue":"2","key":"827_CR234","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28(2):591\u2013605.","journal-title":"Cell Death Differ"},{"key":"827_CR235","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnmol.2014.00073","volume":"7","author":"AH Jansen","year":"2014","unstructured":"Jansen AH, Reits EA, Hol EM. The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front Mol Neurosci. 2014;7:73.","journal-title":"Front Mol Neurosci"},{"key":"827_CR236","doi-asserted-by":"publisher","first-page":"1124907","DOI":"10.3389\/fcell.2023.1124907","volume":"11","author":"K Davidson","year":"2023","unstructured":"Davidson K, Pickering AM. The proteasome: A key modulator of nervous system function, brain aging, and neurodegenerative disease. Front Cell Dev Biol. 2023;11:1124907.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"827_CR237","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41401-021-00778-2","volume":"43","author":"CX Zang","year":"2022","unstructured":"Zang CX, Wang L, Yang HY, et al. HACE1 negatively regulates neuroinflammation through ubiquitylating and degrading Rac1 in Parkinson\u2019s disease models. Acta Pharmacol Sin. 2022;43(2):285\u201394.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"827_CR238","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00429-013-0669-5","volume":"220","author":"IS Pienaar","year":"2015","unstructured":"Pienaar IS, Harrison IF, Elson JL, et al. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson\u2019s disease. Brain Struct Funct. 2015;220(1):479\u2013500.","journal-title":"Brain Struct Funct"},{"issue":"4","key":"827_CR239","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00429-015-1045-4","volume":"221","author":"JL Elson","year":"2016","unstructured":"Elson JL, Yates A, Pienaar IS. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats. Brain Struct Funct. 2016;221(4):2319\u201341.","journal-title":"Brain Struct Funct"},{"issue":"1","key":"827_CR240","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ana.20186","volume":"56","author":"KS McNaught","year":"2004","unstructured":"McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease. Ann Neurol. 2004;56(1):149\u201362.","journal-title":"Ann Neurol"},{"issue":"4","key":"827_CR241","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/01.wnl.0000198511.09968.b3","volume":"66","author":"F Blandini","year":"2006","unstructured":"Blandini F, Sinforiani E, Pacchetti C, et al. Peripheral proteasome and caspase activity in Parkinson disease and alzheimer disease. Neurology. 2006;66(4):529\u201334.","journal-title":"Neurology"},{"key":"827_CR242","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/srep00954","volume":"2","author":"X Lin","year":"2012","unstructured":"Lin X, Cook TJ, Zabetian CP, et al. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Sci Rep. 2012;2:954.","journal-title":"Sci Rep"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00827-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00827-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T02:14:28Z","timestamp":1743041668000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00827-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":242,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["827"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00827-y","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose related to the content of this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"36"}}